Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prosecutors Raid Hanmi HQ As Olmutinib Probe Gets Serious

Executive Summary

Following the start of a probe by financial authorities earlier this month into suspicions Hanmi may have leaked undisclosed information relating to the return of rights to its cancer drug olmutinib, prosecutors have raided the headquarters of the South Korean pharma to get to the bottom of the affair.

Advertisement

Related Content

Korean Authorities Mull New Steps, Probe Over Olmutinib Events
Hanmi Does It Again - RAF Inhibitor Goes To Genentech In $910m Deal

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097490

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel